临床口腔医学杂志
臨床口腔醫學雜誌
림상구강의학잡지
Journal of Clinical Stomatology
2015年
10期
601-602
,共2页
富血小板纤维蛋白%牙龈退缩
富血小闆纖維蛋白%牙齦退縮
부혈소판섬유단백%아간퇴축
目的:采用Choukroun's富血小板纤维蛋白膜(PRF膜)手术治疗牙龈退缩,对治疗前后的临床效果进行评价. 方法:选取有牙龈退缩且有意愿进行PRF手术治疗的MillerⅠ~Ⅱ度患者10例,采用PRF手术,在术前、术后不同时间点(术后3、6、12个月)分别测量牙周袋深度、附着龈宽度、附着丧失,对比治疗前后的临床效果.结果:牙周袋深度术前术后无显著性差异(P>0.05);角化龈宽度增加,术前与术后各组之间有显著性差异(P<0.05);根面达到部分或全部覆盖,术前与术后各组之间有显著性差异(P<0.05). 结论:PRF膜(富血小板纤维蛋白)治疗牙龈退缩MillerⅠ、Ⅱ度病例可以达到很好的临床治疗效果.
目的:採用Choukroun's富血小闆纖維蛋白膜(PRF膜)手術治療牙齦退縮,對治療前後的臨床效果進行評價. 方法:選取有牙齦退縮且有意願進行PRF手術治療的MillerⅠ~Ⅱ度患者10例,採用PRF手術,在術前、術後不同時間點(術後3、6、12箇月)分彆測量牙週袋深度、附著齦寬度、附著喪失,對比治療前後的臨床效果.結果:牙週袋深度術前術後無顯著性差異(P>0.05);角化齦寬度增加,術前與術後各組之間有顯著性差異(P<0.05);根麵達到部分或全部覆蓋,術前與術後各組之間有顯著性差異(P<0.05). 結論:PRF膜(富血小闆纖維蛋白)治療牙齦退縮MillerⅠ、Ⅱ度病例可以達到很好的臨床治療效果.
목적:채용Choukroun's부혈소판섬유단백막(PRF막)수술치료아간퇴축,대치료전후적림상효과진행평개. 방법:선취유아간퇴축차유의원진행PRF수술치료적MillerⅠ~Ⅱ도환자10례,채용PRF수술,재술전、술후불동시간점(술후3、6、12개월)분별측량아주대심도、부착간관도、부착상실,대비치료전후적림상효과.결과:아주대심도술전술후무현저성차이(P>0.05);각화간관도증가,술전여술후각조지간유현저성차이(P<0.05);근면체도부분혹전부복개,술전여술후각조지간유현저성차이(P<0.05). 결론:PRF막(부혈소판섬유단백)치료아간퇴축MillerⅠ、Ⅱ도병례가이체도흔호적림상치료효과.
Objective:To explore the new ways of clinical treatment of gingival Recessions through Clinical Evalua-tion of Choukroun's platelet-Rich-Fibrin (PRF) Membranes. Method:Choose 10 patients of Gingival Recessions intend to surgical treatment,measure periodontal pocket depth,width of attached gingival and loss of attachment level in different time points of preoperative and postoperative (after 2 months,3 months,6 months,1 year),TO contrast the Clinical effect of the Clinical Evaluation of Choukroun's PRF Membranes in Gingival Recessions,Provide theoretical basis for clinic. Result:No significant change in Periodontal pocket depth by surgery (P>0.05);The width keratinized gingival is increasing,A signifi-cant change in it after operation as compared with every group before operation (P <0.05);To cover part or all of root sur-face,A significant change after operation as compared with every group before operation(P<0.05). Conclusion:For gingival Recessions,It can be achieved a better Clinical effects by Platelet-Rich-Fibrin(PRF) Membranes.